Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Omer, Hélène ^a,b   Rose, Graham ^c   Jolley, Keith A ^d   Frapy, Eric ^a,b   Zahar, Jean Ralph ^a,e   Maiden, Martin C J ^d   Bentley, Stephen D ^c   Tinsley, Colin R ^f   Nassif, Xavier ^a,b,e   Bille, Emmanuelle ^a,b,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UMR1319 MICALIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFTRIAXONE; PROTEIN LGTB; PROTEIN MUTS; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BLOOD CULTURE; BRAIN BLOOD VESSEL; CASE REPORT; DISEASE SEVERITY; DNA MODIFICATION; ENDOTHELIUM CELL; FEMALE; FEVER; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MENINGISM; MENINGOCOCCOSIS; MUTATIONAL ANALYSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; PURPURA; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; TRANSCRIPTOMICS; ANTIGENIC VARIATION; CROSS INFECTION; DISEASE TRANSMISSION; GENETICS; IMMUNOLOGY; LABORATORY PERSONNEL; MICROBIOLOGY; OCCUPATIONAL ACCIDENT; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP A;

ACCIDENTS, OCCUPATIONAL; ADULT; ANTIGENIC VARIATION; CROSS INFECTION; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; LABORATORY PERSONNEL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PHENOTYPE;

EID: 79952230538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017145     Document Type: Article

References (69)

1. Yazdankhah SP, Caugant DA, (2004) Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 53 (Pt 9): 821-832.
2. World Health Organization e (1998) Control of epidemic meningococcal disease. WHO practical guidelines 2nd edition.
3. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95 (6): 3140-3145.
4. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369 (9580): 2196-2210.
5. Gotschlich EC, Goldschneider I, Artenstein MS, (1969) Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 129 (6): 1367-1384.
6. Goldschneider I, Gotschlich EC, Artenstein MS, (1969) Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 129 (6): 1327-1348.
7. Densen P, (1989) Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin Microbiol Rev 2 (Suppl): S11-17.
8. Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, et al. (2007) Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis 195 (7): 1071-1077.
9. Hoang LM, Thomas E, Tyler S, Pollard AJ, Stephens G, et al. (2005) Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. Clin Infect Dis 40 (5): e38-42.
10. Vogel U, Frosch M, (1999) Mechanisms of neisserial serum resistance. Mol Microbiol 32 (6): 1133-1139.
11. Tonjum T, Koomey M, (1997) The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure/function relationships-a review. Gene 192 (1): 155-163.
12. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177 (1): 501-510.
13. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, et al. (1027) The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 6 (7): e1001027.
14. Schryvers AB, Morris LJ, (1988) Identification and characterization of the transferrin receptor from Neisseria meningitidis. Mol Microbiol 2 (2): 281-288.
15. Lewis LA, Dyer DW, (1995) Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed to haptoglobin. J Bacteriol 177 (5): 1299-1306.
16. Stojiljkovic I, Hwa V, de Saint Martin L, O'Gaora P, Nassif X, et al. (1995) The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol Microbiol 15 (3): 531-541.
17. Perkins-Balding D, Ratliff-Griffin M, Stojiljkovic I, (2004) Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev 68 (1): 154-171.
18. Krizova P, Musilek M, Kalmusova J, (1997) Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent Eur J Public Health 5 (4): 214-218.
19. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, et al. (2000) Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 38 (12): 4492-4498.
20. Bille E, Zahar JR, Perrin A, Morelle S, Kriz P, et al. (2005) A chromosomally integrated bacteriophage in invasive meningococci. J Exp Med 201 (12): 1905-1913.
21. Bille E, Ure R, Gray SJ, Kaczmarski EB, McCarthy ND, et al. (2008) Association of a bacteriophage with meningococcal disease in young adults. PLoS One 3 (12): e3885.
22. Delany I, Rappuoli R, Scarlato V, (2004) Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidis. Mol Microbiol 52 (4): 1081-1090.
23. Johnson CR, Newcombe J, Thorne S, Borde HA, Eales-Reynolds LJ, et al. (2001) Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis. Mol Microbiol 39 (5): 1345-1355.
24. Snyder LA, Butcher SA, Saunders NJ, (2001) Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp. Microbiology 147 (Pt 8): 2321-2332.
25. Parkhill J, Achtman M, James KD, Bentley SD, Churcher C, et al. (2000) Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404 (6777): 502-506.
26. Martin P, van de Ven T, Mouchel N, Jeffries AC, Hood DW, et al. (2003) Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol Microbiol 50 (1): 245-257.
27. Saunders NJ, Jeffries AC, Peden JF, Hood DW, Tettelin H, et al. (2000) Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol 37 (1): 207-215.
28. Nassif X, Lowy J, Stenberg P, O'Gaora P, Ganji A, et al. (1993) Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol Microbiol 8 (4): 719-725.
29. van der Woude MW, Baumler AJ, (2004) Phase and antigenic variation in bacteria. Clin Microbiol Rev 17 (3): 581-611, table of contents.
30. Bucci C, Lavitola A, Salvatore P, Del Giudice L, Massardo DR, et al. (1999) Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol Cell 3 (4): 435-445.
31. Richardson AR, Yu Z, Popovic T, Stojiljkovic I, (2002) Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A 99 (9): 6103-6107.
32. CDC (1991) Laboratory-acquired meningococcemia-California and Massachusetts. MMWR Morb Mortal Wkly Rep 40 (3): 46-47, 55.
33. CDC (2002) Laboratory-acquired meningococcal disease-United States, 2000. MMWR Morb Mortal Wkly Rep 51 (7): 141-144.
34. Guibourdenche M, Darchis JP, Boisivon A, Collatz E, Riou JY, (1994) Enzyme electrophoresis, sero- and subtyping, and outer membrane protein characterization of two Neisseria meningitidis strains involved in laboratory-acquired infections. J Clin Microbiol 32 (3): 701-704.
35. Boutet R, Stuart JM, Kaczmarski EB, Gray SJ, Jones DM, et al. (2001) Risk of laboratory-acquired meningococcal disease. J Hosp Infect 49 (4): 282-284.
36. Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, et al. (2005) Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol 43 (9): 4811-4814.
37. Athlin S, Vikerfors T, Fredlund H, Olcen P, (2007) Atypical clinical presentation of laboratory-acquired meningococcal disease. Scand J Infect Dis 39 (10): 911-913.
38. Kessler AT, Stephens DS, Somani J, (2007) Laboratory-acquired serogroup A meningococcal meningitis. J Occup Health 49 (5): 399-401.
39. Achtman M, Neibert M, Crowe BA, Strittmatter W, Kusecek B, et al. (1988) Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med 168 (2): 507-525.
40. Sarkari J, Pandit N, Moxon ER, Achtman M, (1994) Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol 13 (2): 207-217.
41. Kellogg DS Jr, Cohen IR, Norins LC, Schroeter AL, Reising G, (1968) Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol 96 (3): 596-605.
42. Schoen C, Blom J, Claus H, Schramm-Gluck A, Brandt P, et al. (2008) Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A 105 (9): 3473-3478.
43. Pelicic V, Morelle S, Lampe D, Nassif X, (2000) Mutagenesis of Neisseria meningitidis by in vitro transposition of Himar1 mariner. J Bacteriol 182 (19): 5391-5398.
44. Morelle S, Carbonnelle E, Matic I, Nassif X, (2005) Contact with host cells induces a DNA repair system in pathogenic Neisseriae. Mol Microbiol 55 (3): 853-861.
45. Geoffroy MC, Floquet S, Metais A, Nassif X, Pelicic V, (2003) Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res 13 (3): 391-398.
46. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J 19 (13): 1872-1874.
47. Coureuil M, Mikaty G, Miller F, Lecuyer H, Bernard C, et al. (2009) Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 325 (5936): 83-87.
48. Li H, Ruan J, Durbin R, (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18 (11): 1851-1858.
49. Assefa S, Keane TM, Otto TD, Newbold C, Berriman M, (2009) ABACAS: algorithm-based automatic contiguation of assembled sequences. Bioinformatics 25 (15): 1968-1969.
50. Carver T, Berriman M, Tivey A, Patel C, Bohme U, et al. (2008) Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24 (23): 2672-2676.
51. Bentley SD, Vernikos GS, Snyder LA, Churcher C, Arrowsmith C, et al. (2007) Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet 3 (2): e23.
52. Choudhury B, Kahler CM, Datta A, Stephens DS, Carlson RW, (2008) The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491. Carbohydr Res 343 (17): 2971-2979.
53. Legrain M, Mazarin V, Irwin SW, Bouchon B, Quentin-Millet MJ, et al. (1993) Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene 130 (1): 73-80.
54. Lewis LA, Gray E, Wang YP, Roe BA, Dyer DW, (1997) Molecular characterization of hpuAB, the haemoglobin-haptoglobin-utilization operon of Neisseria meningitidis. Mol Microbiol 23 (4): 737-749.
55. Richardson AR, Stojiljkovic I, (2001) Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol Microbiol 40 (3): 645-655.
56. Turner DP, Wooldridge KG, Ala'Aldeen DA, (2002) Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. Infect Immun 70 (8): 4447-4461.
57. van Ulsen P, van Alphen L, ten Hove J, Fransen F, van der Ley P, et al. (2003) A Neisserial autotransporter NalP modulating the processing of other autotransporters. Mol Microbiol 50 (3): 1017-1030.
58. Roussel-Jazede V, Jongerius I, Bos MP, Tommassen J, NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface. Infect Immun 78 (7): 3083-3089.
59. Hadi HA, Wooldridge KG, Robinson K, Ala'Aldeen DA, (2001) Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol Microbiol 41 (3): 611-623.
60. Marceau M, Forest K, Beretti JL, Tainer J, Nassif X, (1998) Consequences of the loss of O-linked glycosylation of meningococcal type IV pilin on piliation and pilus-mediated adhesion. Mol Microbiol 27 (4): 705-715.
61. Tinsley CR, Heckels JE, (1986) Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection. J Gen Microbiol 132 (9): 2483-2490.
62. Hagblom P, Segal E, Billyard E, So M, (1985) Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature 315 (6015): 156-158.
63. Seifert HS, Wright CJ, Jerse AE, Cohen MS, Cannon JG, (1994) Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest 93 (6): 2744-2749.
64. Kawai M, Uchiyama I, Kobayashi I, (2005) Genome comparison in silico in Neisseria suggests integration of filamentous bacteriophages by their own transposase. DNA Res 12 (6): 389-401.
65. Wakarchuk W, Martin A, Jennings MP, Moxon ER, Richards JC, (1996) Functional relationships of the genetic locus encoding the glycosyltransferase enzymes involved in expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. J Biol Chem 271 (32): 19166-19173.
66. Weynants V, Denoel P, Devos N, Janssens D, Feron C, et al. (2009) Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect Immun 77 (5): 2084-2093.
67. Snyder LA, Saunders NJ, (2006) The majority of genes in the pathogenic Neisseria species are present in non-pathogenic Neisseria lactamica, including those designated as 'virulence genes'. BMC Genomics 7: 128.
68. Zhu P, Boykins RA, Tsai CM, (2006) Genetic and functional analyses of the lgtH gene, a member of the beta-1,4-galactosyltransferase gene family in the genus Neisseria. Microbiology 152 (Pt 1): 123-134.
69. Craig L, Volkmann N, Arvai AS, Pique ME, Yeager M, et al. (2006) Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol Cell 23 (5): 651-662.